Acorah Software Products - Accounts Production 16.1.300 false true 31 July 2023 1 August 2022 false 1 August 2023 31 March 2024 31 March 2024 13510573 Prof. A Brancale Dr R J McFarlane Dr P M Hotten iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13510573 2023-07-31 13510573 2024-03-31 13510573 2023-08-01 2024-03-31 13510573 frs-core:CurrentFinancialInstruments 2024-03-31 13510573 frs-core:Non-currentFinancialInstruments 2024-03-31 13510573 frs-core:ComputerEquipment 2023-08-01 2024-03-31 13510573 frs-core:FurnitureFittings 2024-03-31 13510573 frs-core:FurnitureFittings 2023-08-01 2024-03-31 13510573 frs-core:FurnitureFittings 2023-07-31 13510573 frs-core:PlantMachinery 2024-03-31 13510573 frs-core:PlantMachinery 2023-08-01 2024-03-31 13510573 frs-core:PlantMachinery 2023-07-31 13510573 frs-core:OtherReservesSubtotal 2024-03-31 13510573 frs-core:ShareCapital 2024-03-31 13510573 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 13510573 frs-bus:PrivateLimitedCompanyLtd 2023-08-01 2024-03-31 13510573 frs-bus:FilletedAccounts 2023-08-01 2024-03-31 13510573 frs-bus:SmallEntities 2023-08-01 2024-03-31 13510573 frs-bus:AuditExempt-NoAccountantsReport 2023-08-01 2024-03-31 13510573 frs-bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-03-31 13510573 frs-bus:Director1 2023-08-01 2024-03-31 13510573 frs-bus:Director2 2023-08-01 2024-03-31 13510573 frs-bus:Director3 2023-08-01 2024-03-31 13510573 frs-countries:EnglandWales 2023-08-01 2024-03-31 13510573 2022-07-31 13510573 2023-07-31 13510573 2022-08-01 2023-07-31 13510573 frs-core:CurrentFinancialInstruments 2023-07-31 13510573 frs-core:Non-currentFinancialInstruments 2023-07-31 13510573 frs-core:OtherReservesSubtotal 2023-07-31 13510573 frs-core:ShareCapital 2023-07-31 13510573 frs-core:RetainedEarningsAccumulatedLosses 2023-07-31
Registered number: 13510573
Awen Oncology Limited
Unaudited Financial Statements
For the Period 1 August 2023 to 31 March 2024
IP Tax Solutions Ltd
Contents
Page
Statement of Financial Position 1—2
Notes to the Financial Statements 3—4
Page 1
Statement of Financial Position
Registered number: 13510573
31 March 2024 31 July 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 186,971 -
186,971 -
CURRENT ASSETS
Debtors 5 179,039 -
Cash at bank and in hand 474,436 53,556
653,475 53,556
Creditors: Amounts Falling Due Within One Year 6 (100,508 ) (58,100 )
NET CURRENT ASSETS (LIABILITIES) 552,967 (4,544 )
TOTAL ASSETS LESS CURRENT LIABILITIES 739,938 (4,544 )
Creditors: Amounts Falling Due After More Than One Year 7 (45,000 ) -
NET ASSETS/(LIABILITIES) 694,938 (4,544 )
CAPITAL AND RESERVES
Called up share capital 9 11 10
Other reserves 750,000 -
Income Statement (55,073 ) (4,554 )
SHAREHOLDERS' FUNDS 694,938 (4,544)
Page 1
Page 2
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
Dr R J McFarlane
Director
25/03/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Awen Oncology Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13510573 . The registered office is M-Sparc, Parc Gwyddoniaeth Menai, Gaerwen, LL60 6AG.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Laboratory Equipment 5 years straight line
Fixtures & Fittings 5 years straight line
Computer Equipment 3 years straight line
2.3. Government Grant
Government grants are recognised in the income statement in an appropriate manner that matches them with the expenditure towards which they are intended to contribute.
Grants for immediate financial support or to cover costs already incurred are recognised immediately in the income statement. Grants towards general activities of the entity over a specific period are recognised in the income statement over that period.
Grants towards fixed assets are recognised over the expected useful lives of the related assets and are treated as deferred income and released to the income statement over the useful life of the asset concerned.
All grants in the income statement are recognised when all conditions for receipt have been complied with.
3. Average Number of Employees
Average number of employees, including directors, during the period was: 1 (2023: NIL)
1 -
4. Tangible Assets
Laboratory Equipment Fixtures & Fittings Total
£ £ £
Cost
As at 1 August 2023 - - -
Additions 190,615 180 190,795
As at 31 March 2024 190,615 180 190,795
Depreciation
As at 1 August 2023 - - -
Provided during the period 3,821 3 3,824
As at 31 March 2024 3,821 3 3,824
Net Book Value
As at 31 March 2024 186,794 177 186,971
As at 1 August 2023 - - -
Page 3
Page 4
5. Debtors
31 March 2024 31 July 2023
£ £
Due within one year
Prepayments and accrued income 123,679 -
VAT 55,360 -
179,039 -
6. Creditors: Amounts Falling Due Within One Year
31 March 2024 31 July 2023
£ £
Trade creditors 4,377 -
Other taxes and social security 464 -
Net wages 653 -
Other creditors 93,719 12,400
Accruals and deferred income 1,295 45,700
100,508 58,100
7. Creditors: Amounts Falling Due After More Than One Year
31 March 2024 31 July 2023
£ £
Other creditors 45,000 -
8. Secured Creditors
Of the creditors the following amounts are secured.
31 March 2024 31 July 2023
£ £
Other Creditors 45,000 -
9. Share Capital
31 March 2024 31 July 2023
£ £
Allotted, Called up and fully paid 11 10
10. Reserves
Other reserves relate to SAFE investments in the company.
Page 4